In order to further improve the production efficiency and product quality of inclusive drugs, the company's R&D center has established five departments, namely the Pharmaceutical Affairs Department (RA), the Formulation Research and Development Department (FR&D), the Analysis Research and Development Department (AR&D), the Clinical Affairs Department (CA), and the Quality Assurance Department (DQA). Each department has independent division of labor and close cooperation, and efficiently cooperates to complete various R&D registration and application work.